These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
374 related items for PubMed ID: 1931822
1. Trans-dominant Tat mutants with alterations in the basic domain inhibit HIV-1 gene expression. Modesti N, Garcia J, Debouck C, Peterlin M, Gaynor R. New Biol; 1991 Aug; 3(8):759-68. PubMed ID: 1931822 [Abstract] [Full Text] [Related]
2. Bovine immunodeficiency virus tat gene: cloning of two distinct cDNAs and identification, characterization, and immunolocalization of the tat gene products. Fong SE, Greenwood JD, Williamson JC, Derse D, Pallansch LA, Copeland T, Rasmussen L, Mentzer A, Nagashima K, Tobin G, Gonda MA. Virology; 1997 Jul 07; 233(2):339-57. PubMed ID: 9217057 [Abstract] [Full Text] [Related]
3. Tat-regulated production of multimerized TAR RNA inhibits HIV-1 gene expression. Lisziewicz J, Rappaport J, Dhar R. New Biol; 1991 Jan 07; 3(1):82-9. PubMed ID: 2039768 [Abstract] [Full Text] [Related]
4. Mutagenesis of EIAV TAT reveals structural features essential for transcriptional activation and TAR element recognition. Derse D, Newbold SH. Virology; 1993 Jun 07; 194(2):530-6. PubMed ID: 8389074 [Abstract] [Full Text] [Related]
5. The acidic amino-terminal region of the HIV-1 Tat protein constitutes an essential activating domain. Rappaport J, Lee SJ, Khalili K, Wong-Staal F. New Biol; 1989 Oct 07; 1(1):101-10. PubMed ID: 2562188 [Abstract] [Full Text] [Related]
6. Synthetic HIV-1 Tat can dissociate HeLa nuclear protein-TAR RNA complexes in vitro: a novel Tat-nuclear protein interaction. Jeyapaul J, Seshamma T, Khan SA. Oncogene; 1991 Sep 07; 6(9):1507-13. PubMed ID: 1923518 [Abstract] [Full Text] [Related]
7. Requirement of the human immunodeficiency virus type 1 env gene sequence for TAR-independent trans activation by Tat from the major immediate-early promoter of murine cytomegalovirus. Kim YS. Biochem Biophys Res Commun; 1994 Sep 15; 203(2):1152-9. PubMed ID: 8093034 [Abstract] [Full Text] [Related]
8. Block of Tat-mediated transactivation of tumor necrosis factor beta gene expression by polymeric-TAR decoys. Brother MB, Chang HK, Lisziewicz J, Su D, Murty LC, Ensoli B. Virology; 1996 Aug 01; 222(1):252-6. PubMed ID: 8806505 [Abstract] [Full Text] [Related]
10. HIV-1 regulatory protein tat induces RNA binding proteins in central nervous system cells that associate with the viral trans-acting-response regulatory motif. Kundu M, Ansari SA, Chepenik LG, Pomerantz RJ, Khalili K, Rappaport J, Amini S. J Hum Virol; 1999 Aug 01; 2(2):72-80. PubMed ID: 10225209 [Abstract] [Full Text] [Related]
13. TAR-independent activation of HIV-1 requires the activation domain but not the RNA-binding domain of Tat. Taylor JP, Kundu M, Khalili K. Virology; 1993 Aug 01; 195(2):780-5. PubMed ID: 8337844 [Abstract] [Full Text] [Related]
19. Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein. Southgate C, Zapp ML, Green MR. Nature; 1990 Jun 14; 345(6276):640-2. PubMed ID: 2190099 [Abstract] [Full Text] [Related]
20. A chimeric human immunodeficiency virus type 1 TAR region which mediates high level trans-activation in both rodent and human cells. Newstein M, Lee IS, Venturini DS, Shank PR. Virology; 1993 Dec 14; 197(2):825-8. PubMed ID: 7504372 [Abstract] [Full Text] [Related] Page: [Next] [New Search]